Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin FlexPro, is a recombinant human growth hormone presented as a solution for injection (pre‑filled pen) for subcutaneous use. It treats growth hormone deficiency in children and adults and is indicated for several growth‑related disorders.

GNH USA supplies Norditropin FlexPro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norditropin FlexPro is a recombinant human growth hormone used to address conditions characterized by impaired growth or short stature. - Growth hormone deficiency in children: promotes linear growth and improves height velocity. - Growth hormone deficiency in adults: enhances body composition, bone density and metabolic profile. - Turner syndrome: supports increase in stature and improves body composition. - Prader‑Willi syndrome: aids in growth and helps normalize body composition. - Chronic renal insufficiency associated short stature: stimulates growth in pediatric patients. - Idiopathic short stature: facilitates height gain when other causes have been excluded.

Norditropin FlexPro may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Injection site pain: mild discomfort at the injection site. - Headache: transient headache reported in some patients. - Joint pain: occasional arthralgia, especially in growing children. - Edema: peripheral swelling, often mild. - Hyperglycemia: elevated blood glucose levels, particularly in predisposed individuals. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Intracranial hypertension: signs include severe headache, visual disturbances. - Slipped epiphysis (epiphyseal plate injury): risk of growth plate fracture. - Severe allergic reaction: rash, urticaria, or anaphylaxis. - Pancreatitis: abdominal pain with elevated enzymes. - Increased intracranial pressure: may present with vomiting and papilledema.

Prior to initiating therapy, clinicians should assess relevant risk factors and monitor patients regularly. - Monitor blood glucose: patients may develop hyperglycemia or diabetes. - Assess thyroid function: hypothyroidism can blunt growth response. - Screen for intracranial lesions: especially in children with unexplained headaches. - Evaluate for scoliosis: growth acceleration may affect spinal curvature. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Somatropin can interact with several medications, altering efficacy or safety.

Major Interactions (Avoid): - Glucocorticoids: may antagonize growth‑promoting effects. - Insulin: may require dose adjustment due to altered glucose metabolism. - Oral estrogen therapy: can reduce somatropin efficacy.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: monitor thyroid status as growth hormone influences metabolism. - Diuretics: may increase risk of edema; monitor fluid balance.